Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Turn Therapeutics Inc. (TTRX) had Return on Tangible Equity of 475.02% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-1.90M |
|
-- |
|
-- |
|
$1.91M |
|
$-1.91M |
|
$0.01M |
|
$-1.90M |
|
$-1.90M |
|
$-1.90M |
|
$-1.90M |
|
$-1.90M |
|
$-1.90M |
|
$-1.91M |
|
$-1.91M |
|
27.98M |
|
27.98M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$3.29M |
|
-- |
|
$1.00M |
|
$4.30M |
|
$2.31M |
|
-- |
|
$1.48M |
|
$3.79M |
|
$0.50M |
|
$-0.40M |
|
$0.50M |
|
28.02M |
|
| Cash Flow Statement Financials | |
$-1.39M |
|
$-0.12M |
|
$3.74M |
|
$0.87M |
|
$3.11M |
|
$2.23M |
|
$0.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.43 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-377.80% |
|
|
Return on Tangible Equity |
475.02% |
-44.31% |
|
-377.80% |
|
$0.02 |
|
$-0.05 |
|
$-0.05 |
|